274 related articles for article (PubMed ID: 21058033)
21. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
[TBL] [Abstract][Full Text] [Related]
22. Prion diseases and their biochemical mechanisms.
Cobb NJ; Surewicz WK
Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
[TBL] [Abstract][Full Text] [Related]
23. Biology and Genetics of PrP Prion Strains.
Ghaemmaghami S
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 27920025
[TBL] [Abstract][Full Text] [Related]
24. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
25. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
26. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
28. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
29. Strain-dependent profile of misfolded prion protein aggregates.
Morales R; Hu PP; Duran-Aniotz C; Moda F; Diaz-Espinoza R; Chen B; Bravo-Alegria J; Makarava N; Baskakov IV; Soto C
Sci Rep; 2016 Feb; 6():20526. PubMed ID: 26877167
[TBL] [Abstract][Full Text] [Related]
30. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.
Bartz JC; Bessen RA; McKenzie D; Marsh RF; Aiken JM
J Virol; 2000 Jun; 74(12):5542-7. PubMed ID: 10823860
[TBL] [Abstract][Full Text] [Related]
31. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
32. Quantitative traits of prion strains are enciphered in the conformation of the prion protein.
Safar J; Cohen FE; Prusiner SB
Arch Virol Suppl; 2000; (16):227-35. PubMed ID: 11214926
[TBL] [Abstract][Full Text] [Related]
33. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
Boyle A; Hogan K; Manson JC; Diack AB
Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
35. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
36. Prion diseases: what is the neurotoxic molecule?
Chiesa R; Harris DA
Neurobiol Dis; 2001 Oct; 8(5):743-63. PubMed ID: 11592845
[TBL] [Abstract][Full Text] [Related]
37. Prion Strain Diversity.
Bartz JC
Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27908925
[TBL] [Abstract][Full Text] [Related]
38. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
39. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
40. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]